Home - Products - Neuroscience - P2 Receptor - TAPI-1 trifluoroacetate

TAPI-1 trifluoroacetate

CAS No. ——

TAPI-1 trifluoroacetate ( —— )

Catalog No. M17699 CAS No. ——

TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	580	Get Quote
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

TAPI-1 trifluoroacetate
Note

Research use only, not for human use.
Brief Description

TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors.
Description

TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Neuroscience
Target

P2 Receptor
Recptor

ADAM17/TACE
Research Area

——
Indication

——

Chemical Information

CAS Number

——
Formula Weight

613.62
Molecular Formula

C28H38F3N5O7
Purity

>98% (HPLC)
Solubility

——
SMILES

O=C(N[C@@H](C)C(NCCN)=O)[C@@H](NC(C(CC(NO)=O)CC(C)C)=O)CC1=CC2=CC=CC=C2C=C1.FC(F)(C(O)=O)F
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Müllberg J, et al. J Immunol. 1995, 155(11), 5198-5205

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

UDP disodium salt

UDP is a specific agonist of the P2Y6 receptors (EC50 = 13 nM for human P2Y6) stimulating the production of inflammatory mediators phagocytosis and vasoconstriction. UDP also acts as an antagonist of P2Y14.
AF 353

AF-353 is a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist, inhibits human and rat P2X3 (pIC50= 8.0).
Glycitein

Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.

Sign In Join Free